Insider Transactions and Holdings
-
Entity Type
-
Company
-
Role
-
10%+ Owner
-
Stock Symbol
-
TTOO on Nasdaq
CR Group L.P. - trading volume in the past year for T2 Biosystems, Inc.
Holdings reported by CR Group L.P. for T2 Biosystems, Inc.
| Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
4.7M |
$741K |
$0.16 |
May 9, 2024 |
By CRG Partners III - Parallel Fund B (Cayman) L.P. |
|
|
| Series A Convertible Preferred Stock |
28K |
|
|
Apr 12, 2024 |
By CRG Partners III - Parallel Fund B (Cayman) L.P. |
Common Stock |
|
| Series A Preferred Stock |
0 |
|
|
May 9, 2024 |
By CRG Partners III - Parallel Fund B (Cayman) L.P. |
Common Stock |
|
| Series B Preferred Stock |
0 |
|
|
May 9, 2024 |
By CRG Partners III - Parallel Fund B (Cayman) L.P. |
Common Stock |
|
Transactions reported by CR Group L.P. for T2 Biosystems, Inc.
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.